Efficiency analysis of toxoplasmosis screening in pregnancy: comment.
Hassl
A
A
D001317:Austria; D003362:Cost-Benefit Analysis; D005260:Female; D005387:Finland; D006801:Humans; D008403:Mass Screening / Q000639:trends; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000191:economics / Q000517:prevention & control*; D014123:Toxoplasmosis / Q000191:economics / Q000517:prevention & control*